Appendicitis in cystic fibrosis.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 1792851)

Published in Arch Dis Child on March 01, 1991

Authors

M D Shields1, H Levison, J J Reisman, P R Durie, G J Canny

Author Affiliations

1: Department of Paediatrics, Hospital for Sick Children, Toronto.

Articles by these authors

Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr (1984) 9.61

Management of asthma: a consensus statement. Arch Dis Child (1989) 7.04

Prediction of mortality in patients with cystic fibrosis. N Engl J Med (1992) 5.46

The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). N Engl J Med (1990) 4.70

A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol (1988) 4.41

Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J Pediatr (1997) 3.38

Bronchial reactivity in cystic fibrosis. Pediatrics (1978) 2.70

Standards of pulmonary function in children. Am Rev Respir Dis (1969) 2.56

Sustained-release theophylline for childhood asthma: evidence for circadian variation of theophylline pharmacokinetics. J Pediatr (1981) 2.41

Pulmonary function abnormalities in symptom-free children after bronchiolitis. Pediatrics (1977) 2.32

Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr (1990) 2.28

Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med (1984) 2.22

Comparison of albuterol delivered by a metered dose inhaler with spacer versus a nebulizer in children with mild acute asthma. J Pediatr (1999) 2.08

High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet (1987) 2.05

Five- to seven-year course of pulmonary function in cystic fibrosis. Am Rev Respir Dis (1976) 2.03

Pulmonary function and bronchial hyperreactivity in long-term survivors of bronchopulmonary dysplasia. Pediatrics (1981) 2.00

Ultrastructure of airways in children with asthma. Histopathology (1978) 1.97

A randomized controlled trial of a 3-year home exercise program in cystic fibrosis. J Pediatr (2000) 1.93

Hepatic abscess and cystic fibrosis. Postgrad Med J (1988) 1.77

Microvillus inclusion disease: an inherited defect of brush-border assembly and differentiation. N Engl J Med (1989) 1.77

Role of conventional physiotherapy in cystic fibrosis. J Pediatr (1988) 1.75

Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J Pediatr (1995) 1.70

DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis. Am J Hum Genet (1989) 1.66

Diabetes mellitus in patients with cystic fibrosis: effect on survival. Pediatrics (1990) 1.65

Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr (1982) 1.64

Increased incidence of bronchial reactivity in children with a history of bronchiolitis. J Pediatr (1981) 1.62

Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia. J Antimicrob Chemother (1983) 1.60

Clinical and physiological assessment of asthmatic children treated with beclomethasone dipropionate. J Allergy Clin Immunol (1976) 1.59

Transit time analysis of the forced expiratory vital capacity in cystic fibrosis. Am Rev Respir Dis (1976) 1.58

Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma. J Pediatr (1995) 1.56

Severe acute asthma in a pediatric intensive care unit: six years' experience. Pediatrics (1989) 1.54

Volume of isoflow. A new test in detection of mild abnormalities of lung mechanics. Am Rev Respir Dis (1974) 1.53

Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease. Am J Med (1985) 1.52

Pulmonary function in children with asthma at acute attack and symptom-free status. Am Rev Respir Dis (1969) 1.52

The approach to chronic cough in childhood. Ann Allergy (1988) 1.51

Energy expenditure of patients with cystic fibrosis. J Pediatr (1987) 1.51

High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med (1997) 1.51

Mucociliary tracheal transport rates in man. J Appl Physiol (1975) 1.50

Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. Gut (1980) 1.50

Acute pancreatitis in childhood. J Pediatr (1988) 1.49

Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. J Pediatr (1999) 1.47

Lung function in children following repair of tracheoesophageal fistula. J Pediatr (1979) 1.46

Airway closure in children. J Appl Physiol (1972) 1.45

Hypoalbuminemia at initial examination in patients with cystic fibrosis. J Pediatr (1989) 1.45

A position paper of the North American Society for Pediatric Gastroenterology and Nutrition. Pediatric gastroenterology Workforce Survey and future supply and demand. J Pediatr Gastroenterol Nutr (1998) 1.45

Bile acid secretion in cystic fibrosis: evidence for a defect unrelated to fat malabsorption. Gut (1986) 1.44

Childhood asthma: a rational approach to treatment. Ann Allergy (1990) 1.44

Spacers in childhood asthma--is there one for all occasions? Ann Allergy (1990) 1.43

Maximal expiratory flows generated by rapid chest compression following end-inspiratory occlusion or expiratory clamping in young children. Eur Respir J (1995) 1.41

Transcutaneous monitoring of oxygenation: what is normal? J Pediatr (1986) 1.37

Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus. J Pediatr (1989) 1.37

Changes in ventilation and chest wall mechanics during sleep in normal adolescents. J Appl Physiol Respir Environ Exerc Physiol (1981) 1.36

Spacing devices and metered-dose inhalers in childhood asthma. J Pediatr (1985) 1.35

Sodium cromoglycate-induced changes in the dose-response curve of inhaled methacholine and histamine in asthmatic children. Am Rev Respir Dis (1979) 1.35

Intermittent positive pressure respiration as a treatment in severe respiratory distress syndrome. Arch Dis Child (1965) 1.34

Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency. Pediatr Res (1986) 1.34

Pregnancy and cystic fibrosis. Obstet Gynecol (1991) 1.33

The response to exercise in normal and asthmatic children. J Pediatr (1978) 1.32

Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Pediatr Pulmonol (1989) 1.31

Respiratory function and cosmesis at maturity in infantile-onset scoliosis. Spine (Phila Pa 1976) (2003) 1.31

High-versus low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma. Pediatrics (1989) 1.30

Effects of long-term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis. J Pediatr (1985) 1.30

Pulmonary function in infants and children following the acute neonatal respiratory distress syndrome. Bull Physiopathol Respir (Nancy) (1974) 1.30

Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatr (1993) 1.30

Early detection of pulmonary function abnormalities in cystic fibrosis. Pediatrics (1972) 1.29

Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group. J Pediatr Gastroenterol Nutr (1999) 1.28

Treatment of distal intestinal obstruction syndrome in cystic fibrosis with a balanced intestinal lavage solution. Lancet (1986) 1.28

Pathology of pancreatic and intestinal disorders in cystic fibrosis. J R Soc Med (1998) 1.28

Skeletal phenotype in patients with Shwachman-Diamond syndrome and mutations in SBDS. Clin Genet (2004) 1.27

Acute asthma: observations regarding the management of a pediatric emergency room. Pediatrics (1989) 1.27

Ventilatory muscle endurance training in normal subjects and patients with cystic fibrosis. Am Rev Respir Dis (1977) 1.26

Alpha 1 antitrypsin deficiency in association with both cirrhosis and chronic obstructive lung disease in two sibs. Am J Med (1973) 1.26

Evidence for a primary defect of pancreatic HCO3-secretion in cystic fibrosis. Pediatr Res (1982) 1.26

Uncertainty in the diagnosis of cystic fibrosis: possible role of in vivo nasal potential difference measurements. J Pediatr (1998) 1.26

Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expression. Gastroenterology (1996) 1.25

Combined salbutamol and ipratropium bromide by inhalation in the treatment of severe acute asthma. J Pediatr (1985) 1.25

Relative sensitivity of methods for measuring airway resistance in asthmatic children. Ann Allergy (1969) 1.25

A comparison of infra-red and convective heating for newborn infants. Lancet (1966) 1.25

Protease inhibitors in patients with chronic obstructive pulmonary disease: the alpha-antitrypsin heterozygote controversy. Am Rev Respir Dis (1976) 1.24

Chronic illness in infancy and parenting stress: a comparison of three groups of parents. J Pediatr Psychol (1990) 1.24

Nebulized albuterol in acute bronchiolitis. J Pediatr (1990) 1.23

Cystic fibrosis patients bearing both the common missense mutation Gly----Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileus. Am J Hum Genet (1992) 1.22

Pseudomonas aeruginosa and Burkholderia cepacia infection in cystic fibrosis patients treated in Toronto and Copenhagen. Pediatr Pulmonol (1998) 1.22

Shwachman-Diamond syndrome with exocrine pancreatic dysfunction and bone marrow failure maps to the centromeric region of chromosome 7. Am J Hum Genet (2001) 1.21

The pulmonary syndrome of Wilson and Mikity. Pediatrics (1965) 1.21

Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis. Pediatr Infect Dis (1985) 1.19

Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Delineation of patients with steatorrhea secondary to relative colipase deficiency. Gastroenterology (1984) 1.17

Mechanism of hemoglobin desaturation during rapid-eye-movement sleep in normal subjects and in patients with cystic fibrosis. Am Rev Respir Dis (1980) 1.17

Physical signs in childhood asthma. Pediatrics (1976) 1.17

Bronchial hyperreactivity in cystic fibrosis and asthma. J Pediatr (1978) 1.16

Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. J Pediatr (1995) 1.16

Effects of ultrasonically nebulized distilled water on airway dynamics in children with cystic fibrosis and asthma. J Pediatr (1972) 1.16